Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a Dose-Finding Trial of KDS2010 in Overweight or Obese Patients
KCT0010560Phase 2Recruiting
- Sponsor
- NeuroBiogen
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tisolagiline in Overweight, obesity, sponsored by NeuroBiogen. Started Jul 2025; status: recruiting.
02
Drugs
tisolagiline
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on KCT0010560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010560.